Frontiers in Molecular Biosciences (Dec 2021)

Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma

  • Jian Zhang,
  • Jian Zhang,
  • Xinxin Miao,
  • Xinxin Miao,
  • Tianlong Wu,
  • Tianlong Wu,
  • Jingyu Jia,
  • Xigao Cheng,
  • Xigao Cheng,
  • Xigao Cheng

DOI
https://doi.org/10.3389/fmolb.2021.751842
Journal volume & issue
Vol. 8

Abstract

Read online

Osteosarcoma is a malignant tumor that originates in the bones with the characteristics of high malignancy, predisposition to metastasis, and poor prognosis. RNA binding proteins (RBPs) are closely related to various tumors, but their relationship with osteosarcoma remains unclear. Based on GTEx and TARGET RNA sequencing data, we applied differential analysis to obtain RBP genes that are differentially expressed in osteosarcoma, and analyzed the functions of these RBPs. After applying univariate and LASSO Cox regression analysis, 10 key prognostic RBPs (TDRD6, TLR8, NXT2, EIF4E3, RPS27L, CPEB3, RBM34, TERT, RPS29, and ZC3HAV1) were screened, and an RBP prognostic risk assessment model for patients with osteosarcoma was established. The independent cohort GSE21257 was used for external verification, and the results showed that the signature has an excellent ability to predict prognosis. In addition, a nomogram that can be used for clinical evaluation was constructed. Finally, the expression levels of 10 prognostic RBPs in osteosarcoma cells and tissues were confirmed through experiments. Our study identified a ten-gene prognostic marker related to RBP, which is of great significance for adjusting the treatment strategy of patients with osteosarcoma and exploring prognostic markers.

Keywords